Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 49315-008

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 49315-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg/10ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 01)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) injectable, liposomal formulation for intravenous use. The label states it is sterile, must be refrigerated at 2° to 8°C, and is a single-dose 10 mL vial. It is manufactured by Cadila Healthcare Limited, Ahmedabad, India, and labeled by Zydus Lifesciences Limited. The label includes warnings about dilution and that it is a cytotoxic agent.*

FDA Label Image

20 mg/10 mL Carton Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 02)

Label for DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) injectable liposomal formulation by Zydus Lifesciences Limited. The label specifies this cytotoxic agent is for intravenous infusion only and must be diluted, highlighting it is a liposomal formulation not substitutable for doxorubicin HCl. Storage instructions and single-dose vial details are included.*

FDA Label Image

50 mg/25ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 03)

DOXOrubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) injectable liposomal formulation vial label. Labeled for intravenous use only, single-dose 25 mL vial. Manufactured by Cadila Healthcare Limited, Ahmedabad, India, and distributed by Zydus Pharmaceuticals. Storage instructions specify refrigeration at 2° to 8°C and not to freeze. Includes dosage note to see package insert.*

FDA Label Image

50 mg/25 mL Carton Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 04)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection, 50 mg per 25 mL (2 mg/mL) injectable, liposomal formulation for intravenous use. The label indicates it is a cytotoxic agent requiring dilution, supplied in a 25 mL single-dose vial. Manufactured by Zydus Lifesciences Limited, the label includes storage instructions, warnings against substitution, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.